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ABSTRACT 
Background:  
A method of definitive diagnosis is essential for the patients who 
present with palpable breast lump at the outpatient department. The 
method must be accurate, easy to perform and acceptable to the patient, 
safe, can be carried out in a busy clinic setting and must not require too 
much preparation or expensive equipment.
1,2
 A study, to compare the 
diagnostic accuracy of Fine Needle Aspiration Cytology (FNAC) and 
Tru-cut Biopsy, was conducted to differentiate between benign & 
malignant lesions of palpable lump in breast and to evaluate the validity 
of FNAC in arriving at a diagnosis with histopathological correlation.  
Objectives:  
1) To compare the diagnostic accuracy of fine needle aspiration 
cytology and tru-cut biopsy in differentiating benign and 
malignant lesion of palpable lump in breast with cytological and 
histopathological correlation.  
2) To analyze the sensitivity, specificity, positive and negative 
predictive values and the efficacy of fine needle aspiration 
cytology and tru-cut biopsy 
  
3) To compare the cytological grade with histological grade in 
surgical specimens. 
4) How an OP procedure of FNAC can be effective in arriving at 
diagnosis in carcinoma breast as treatment 
Methods:  
A prospective study on breast aspirates and biopsy was done over a 
12- month period from September 2014 to September 2015. All patients 
presenting with palpable breast lesions to the Department of General 
Surgery, Coimbatore Medical College Hospital were subjected to FNAC 
procedure after a detailed history, general physical and local examination 
and the results of 76 cases were categorized into 5 groups C1 through C5 
as per the National Health Service Breast Screening Program (NHSBSP) 
criteria. Where C5 category diagnosis was made, the cytomorphology of 
the malignant lesion was graded using Robinson’s criteria.  
Subsequent to the reporting, the patients are subjected to tru-cut 
biopsy with histopathological correlation. Cytology reporting was 
compared with histopathological report to determine its diagnostic 
accuracy. Using the Scarff Bloom Richardson grading system, 
histological grading was done.  
 
  
Results 
The results showed 0 case in the C1 category, 44 cases in the C2 
category, 2 cases in the C3 category, 1 case in the C4 category, and 29 
cases in the C5 category. 
In the C2 category of benign cases, fibroadenoma was the 
commonest lesion. In the C5 category of malignant cases, invasive ductal 
carcinoma was the most common lesion.  
The accuracy rate of diagnosing a palpable lump in breast by fine 
needle aspiration cytology (FNAC) as a benign lesion – 100%, as 
malignant lesion- 94.73%, having a false negative rate of 9.3%, having 
false positive rate of 2.2%.  
In this study, the sensitivity of FNAC in detecting a malignant 
breast lesion was 90.62%, and specificity was 97.72%, with a positive 
predictive value of 96.66% and a negative predictive value of 93.47%, 
with an inadequate sampling rate of 3.9%.  
The accuracy rate of diagnosing a palpable breast lump by tru-cut 
biopsy as benign lesion was 100% and as a malignant lesion 97.36%, 
having a false negative rate of 6% and with a false positive rate of zero.  
 
  
In this study, the sensitivity of tru-cut biopsy in detecting a 
malignant lesion was 93.93%, specificity was 100%, with a positive 
predictive value of 100% and a negative predictive value of 95.55%. 
Inadequate sampling rate was 2.6% in our study. 
Based on Robinson grading system the cases were classified into 
grade I (14%), grade II (52%) and grade III (34%). Based on Scarff 
Bloom Richardson grading method the cases were classified into grade I 
(6%), grade II (55%) and grade III (39%). Spearman’s correlation 
coefficient of 0.5 was calculated which indicated positive correlation 
between the two grading systems.  
Conclusion 
The diagnostic efficacy, sensitivity and specificity observed in this 
study by FNAC were comparable to that observed in Tru-cut biopsy and 
those given in other texts. Hence FNAC stands as an effective and valid 
tool as the first line diagnostic modality in the preoperative diagnosis of 
both benign and malignant lesions. 
A positive correlation was also observed between Robinson 
cytological grading system and Scarff Bloom Richardson histological 
grading system. Discordance between cytologic grading and histologic 
grading was seen only in few cases.   
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INTRODUCTION 
Breast cancer is the second most common cancer among Indian 
females. The cumulative incidence in females until 64 years of age is  
1-2%.
1
 
Fine needle aspiration cytology (FNAC) is increasingly being used 
for preoperative diagnosis of breast cancer in order to determine various 
prognostic parameters so that the best therapy that can be offered to the 
patients.
2
 
FNAC of the breast can be done on both palpable and nonpalpable 
lesions, the latter with the help of imaging techniques like ultrasound and 
mammography with stereotaxis. The advantages are- it provides rapid and 
accurate diagnosis, has therapeutic value in cystic conditions. The scope 
of cytology now extends into identifying the subtypes of benign and 
malignant breast lesions. It has been shown that FNA may provide added 
information such as the intrinsic features of tumor and hence be helpful in 
prognostication of the tumor factors like nuclear grading, mitotic index 
and DNA contents.
4
 Thus, it plays a major role as an important 
preoperative assessment procedure along with clinical correlation and 
imaging which are referred to as the “Triple test.”
3  
  
 
2 
 
Histologic type and nuclear grade are two vital morphologic 
prognostic factors of breast cancer.
6
 
Cytologic grading has shown a positive correlation with the 
histological grade and hence cytograde is important in predicting the 
histopathologic grade preoperatively. Cytologic grade would thus provide 
relevant information on the tumor biologic behavior and could be a useful 
parameter to take into consideration when selecting neoadjuvant therapy.
3
 
According to the National Cancer Institute Bethesda, grade of 
tumor in the FNA tissue should be included in FNAC report for purpose 
of prognostification. Also importance was laid on the cytological grading 
system which would correspond closely to the grading system used in 
histological material.
2
 
FNAC has been used extensively for the diagnosis of breast lesions 
over the past 25 years. More recently, Tru-cut biopsy has been introduced 
for the diagnosis of breast malignancies. This is perhaps due to the fact 
that grading of tumors and an ER and PR receptor status can easily be 
performed on a Tru-cut biopsy as compared to FNAC and this knowledge 
is used by the treating clinician who wants to use chemotherapy as the 
first line of treatment for breast cancers.
2
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The principal aim of Tru-cut biopsy is to provide a valid 
preoperative diagnosis of a breast lesion and avoid the need for an open 
surgical biopsy. Despite its advantages it is still used as an additional 
investigation tool when FNAC fails to produce a diagnosis.
4
 Certain types 
of lesions present diagnostic difficulty even with Tru-cut biopsy and 
require excision of the mass. These are spindle cell lesions, fibroepithelial 
lesions with cellular stroma, phyllodes tumors, papillary lesions, 
mucinous lesions, radial scar, atypical proliferative lesions including 
atypical ductal hyperplasia, fibroepithelial atypia, and lobular neoplasm.
4
  
Hence this study was performed to analyze the extent to which a 
preliminary diagnosis by FNAC from breast lump correlates with final 
histopathological report.  
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AIMS & OBJECTIVES 
 
1. To compare the diagnostic accuracy of fine needle aspiration 
cytology and tru-cut biopsy in differentiating benign and 
malignant lesions of palpable lump in breast cytological and 
histopathological correlation.  
2. To analyze sensitivity, specificity, positive and negative 
predictive values and the efficacy of fine needle aspiration 
cytology and tru-cut biopsy. 
3. To compare the cytological grade with histological grade in 
surgical specimens. 
4. How an OP procedure of FNAC can be effective in arriving at 
diagnosis in carcinoma breast as treatment.  
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REVIEW OF LITERATURE 
Embryology 
By 4th week, a pair of epidermal thickenings called the mammary 
ridges develops along either side of the body from the area of future 
axilla to the future inguinal region. These ridges normally disappear 
except for the central 1/3rd where the breast develops. This remnant of 
the mammary ridge produces the primary bud in the 5th week that grows 
down into the underlying dermis. By 10th week, the primary bud begins 
to branch and by 12th week several secondary buds have formed. These 
buds lengthen and branch throughout the remainder of gestation. By birth 
about 15 – 25 lactiferous ducts open onto a small superficial depression 
called mammary pit. Proliferation of underlying mesoderm converts the 
pit to an elevated nipple within few weeks of birth 68. 
ANATOMY OF THE BREAST
10 
The breast or mammary gland, a modified sweat gland, is a vital 
accessory organ of female reproductive system.  
Situation 
The breast lies in the superficial fascia of the pectoral region. A 
small extension called the axillary tail of Spence, pierces the deep fascia 
and lies in the axilla. 
  
 
6 
 
Extent 
Vertically, it extends from the second to the sixth rib and 
horizontally, it extends from the lateral border of the sternum to the mid-
axillary line. 
Deep relations 
1) The breast lies on the deep fascia covering the pectoralis major. 
2) Still deeper there are the parts of three muscles, namely the 
pectoralis major, the serratus anterior, and the external oblique 
muscle of the abdomen. 
3) The breast is separated from deep fascia by loose areolar tissue.  
The Skin 
 It covers the gland. A conical projection called the nipple is present 
just below the centre of the breast at the level of fourth intercostal space. 
The nipple is pierced by 15 to 20 lactiferous ducts. It contains circular 
and longitudinal smooth muscle fibers which can make the nipple stiff or 
flatten it, respectively. The skin surrounding the base of the nipple is 
pigmented and forms a circular area called the areola. 
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Figure A : Normal structure of breast. 
The Parenchyma 
 It is made up of glandular tissue; the gland consists of 15 to 20 
lobes. Each lobe is a cluster of alveoli and it is drained by lactiferous 
duct. The lactiferous ducts converge towards the nipple and open on it. 
Near its termination each duct has a dilatation called a lactiferous sinus.  
The Stroma 
 The fibrous stroma forms septa known as the suspensory ligaments 
(of Cooper) and the fatty stroma forms the main bulk of the gland. 
Blood supply 
 The mammary gland is extremely vascular. It is supplied by 
branches of the following arteries. 
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1. Internal thoracic artery, a branch of the subclavian artery. 
2. The lateral thoracic, superior thoracic and acromiothoracic 
branches of the axillary artery. 
3. Lateral branches of the posterior intercostals arteries. 
4. The veins follow the arteries. The superficial veins drain into the 
internal thoracic vein and into the superficial veins of the lower 
part of the neck. The deep veins drain into the internal thoracic, 
axillary and posterior intercostals veins. 
Nerve supply 
 The breast is supplied by the anterior and lateral cutaneous 
branches of the 4th to 6th intercostals nerves. The nerves convey sensory 
fibers to the skin, and autonomic fibers to smooth muscle and to blood 
vessels. 
LYMPHATIC DRAINAGE OF THE BREAST
10
 
 Lymphatic drainage of the breast assumes great importance to the 
surgeon because, carcinoma of the breast spreads mostly along 
lymphatics to the regional lymph nodes. 
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Lymph Nodes 
Lymph from the breast drains in to the following lymph nodes. 
 The axillary lymph nodes, chiefly the anterior (or pectoral) 
group, the posterior, lateral, central and apical groups of nodes 
also receive lymph from the breast either directly or indirectly. 
 The internal mammary (parasternal) nodes which lie along the 
internal thoracic vessels. 
 Some lymph from the breast also reaches the supraclavicular 
nodes, the cephalic (deltopectoral) node, the posterior intercostals 
nodes (lying in the front of the heads of the ribs), 
subdiaphragmatic and subperitoneal lymph plexuses. The 
lymphatics pass radially to the surrounding lymph nodes 
(axillary, internal mammary, supraclavicular and cephalic). 
 The deep lymphatics drain the parenchyma of the breast. They 
also drain the nipple and areola. 
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AXILLARY LYMPH NODES
8
 
ANTERIOR group:  
 Lies along the lateral thoracic vein under anterior axillary fold 
mainly along the third rib. It lies in contact with axillary tail of Spence 
and hence carcinoma located at this site is likely to ne misdiagnosed as 
lymphadenopathy. The anterior axillary nodes may be involved by direct 
continuity of tissue. 
POSTERIOR group:  
 Lie along the subscapular vessels in relation to the posterior 
axillary fold.  
LATERAL group:  
 Lies in relation to axillary vein along upper part of humerus.  
CENTRAL group:  
 Located in the fat of the upper part of the axilla. The 
intercostobrachial nerve passes outwards amongst these nodes. 
Enlargement of these nodes, may cause pressure on the nerve, causing 
pain in the distribution of the nerve along the inner border of the arm. 
  
 
11 
 
APICAL group:  
 Also known as “infraclavicular lymph nodes” are important lymph 
nodes lying below by the 1st intercostal space, behind by the axillary 
vein, in front by the costocoracoid membrane. These nodes lie very 
deeply, but can be palpated by pushing the fingers of one hand into the 
axillary apex from below and the fingers of the other hand behind the 
clavicle from above. 
 They are of great importance because they receive one vessel 
directly from the upper part of the breast and ultimately most of the 
lymph from the breast. 
 A single trunk leaves the apical group on each side of the 
subclavian trunk, and enters the junction of the jugular and subclavian 
veins, or may join the thoracic duct on the left. 
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LYMPHATIC DRAINAGE 
8
 
The breast is drained by two sets of lymphatics: 
1. The lymphatics of the skin over the breast. 
2. The lymphatics of the parenchyma of the breast.  
LYMPHATIC OF THE OVERLYING SKIN:  
 These drain the integument over the breast, but not the skin of the 
areola and nipple. They pass in a radial direction and end in the 
surrounding nodes. Those from the outer side go to the axillary nodes. 
The skin of the upper part drains by vessels that go to the supraclavicular 
nodes (members of the lower deep cervical nodes). Certain of these 
vessels may end in the cephalic node, which lies in relation to the vein of 
the same name in the deltopectoral triangle. The vessels from the skin 
over the inner part of the breast drain to the internal mammary nodes, 
which lie in relation to the veins of that name. These nodes lie in the 
upper four or five intercostal spaces or behind the related coastal 
cartilages. 
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 The lymphatics of the skin over the breast communicate across the 
middle line, and a unilateral disease may become bilateral by this route. 
Mammary cancer may spread along these superficial lymphatic vessels to 
produce nodules in the skin. 
LYMPHATICS OF THE PARENCHYMA OF THE BREAST:  
 The subareolar lymph plexus of Sappey is a collection of large 
lymph vessels situated under the areola. Though the subareolar plexus 
communicates with the lymphatics of the breast tissue, it is not a 
collecting zone for the breast lymph The axillary nodes receive about 75 
per cent of lymph draining the breast tissue. Lymphatics arising in the 
lobules pass directly outwards in the substance of the breast, receive 
tributaries on the way, and pass though the axillary tail to the axilla. Most 
to the anterior group of nodes; a few pass to the posterior group, and from 
there they run to central and apical group. 
 Lymphatics form the deep surface of the breast pass through the 
great pectoral muscle on their way to the axillary or internal mammary 
nodes.The lymphatic plexus of the deep fascia consists of fine vessels, 
which do not act as a normal pathway for lymph from the breast to the 
regional nodes. 
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 The internal mammary nodes receive lymph from both the medial 
and lateral portions of the breast. Lymph enters the thorax along the 
anterior perforating branches of the internal mammary artery and along 
the lateral perforating branches of the intercostals vessels. Most of this 
lymph goes to the internal mammary chain, but a small amount may pass 
to the posterior intercostal nodes lying near the head of the ribs. 
 At the level of the first interspace, fine lymphatics connect the right 
and left internal mammary chains behind the manubrium sterni, and 
nodes may be found there. Even in apparently early breast cancer, tumors 
of the outer half of the breast may metastasize to the internal mammary 
nodes without involvement of the axilllarynodes. 
An efficient and accurate evaluation can maximize cancer detection 
and minimize unnecessary testing and procedures. For effective 
management, multidisciplinary approach is essential.
13
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HISTOLOGY 
The human breast consists of 6- 10 major ductal system. At the 
orifice of the nipple, keratinizing squamous epithelium changes into two-
layered cuboidal epithelium lining ducts. The larger ducts successively 
branches and ends as terminal lobular duct unit. In some women the ducts 
extend into the axilla and chest wall. There are 2 types of cells which line 
the lobules and duct. The myoepithelial contractile cells line the basement 
membrane, and help in ejection of milk at the time of lactation and 
support lobules. Overlying the myoepithelial cells are the luminal cells 
which produce milk. There are two types of breast stroma. The interlobar 
stroma consists of dense fibrous connective tissue admixed with adipose 
tissue. The intralobular stroma envelopes the acini of lobules and consists 
of breast specific hormonally responsive fibroblasts like cells admixed 
with lymphocytes.
69
 
Changes in the breasts are most dynamic and profound during 
reproductive years. Just as the endometriun grows and ebbs with each 
menstrual cycle, so does the breast. 
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During first half of menstrual cycle, lobules are relatively 
quiescent. After ovulation ,under the influence of estrogen and 
progesterone, cell proliferation increases, as does the acini per lobule. 
The intralobular stroma becomes markedly edematous. Upon 
menstruation.the fall in progesterone and estrogen levels induces the 
regression of lobules and the disappearance of stromal edema. After the 
third decade, long before menopause, lobules and there specialized 
stroma start to involute. Lobular atrophy may be complete in elderly 
females. The radiodense fibrous tissue of young female is progressively 
replaced by radiolucent adipose tissue.
70
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SYMPTOMATOLOGY 
Most common symptoms reported by women are pain, nipple 
discharge and palpable mass.
71
 
- Pain (mastalgia) is the most common breast symptom. It can be 
caused by a ruptured cyst, area of prior injury / infection. But most 
often, no specific lesion is identified.
72
 
- Nipple discharge is a less common presenting symptom but of 
concern when it is spontaneous and unilateral. A discharge 
produced by manipulating the breast is normal and unlikely to be 
associated with a pathologic lesion. Serous discharge is most 
commonly associated with benign lesions but rarely can be due to 
malignancy.  Palpable mass is a fairly common breast symptom. A 
breast lesion usually does not become palpable until it is about 2 
cms diameter. The most commonly encountered lesions are 
fibroadenoma, cysts and invasive breast cancer. The likelihood that 
a palpable mass is malignant increases with age. Cancer of the 
breast is a common human neoplasm accounting for approximately 
1/4th of all cancers in females. Approximately 50% of cancers 
arise in upper outer quadrant, 10% in each of remaining quadrant 
and about 20% in central / subareolar region. Early detection and 
advances in treatment have begun to reduce mortality rates
72. 
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Detection and diagnosis of breast lump 
Education of the public about the fundamental facts of cancer and 
self- examination of the breast represents an important factor in the early 
detection of breast disease. The clinical signs of primary breast neoplasm 
are few. In the over whelming majority of cases, there is a painless breast 
mass and less frequently nipple discharge of erosion, skin retraction, or 
an axillary mass.
2 
Physical examination, mammography, ultrasonography, core 
needle biopsy, open excision biopsy, thermography, fine needle 
aspiration cytology are important diagnostic modalities which have 
greater or lesser degrees of contribution in the detection of palpable lump 
in breast. To increase the sensitivity and specificity of the approaches, 
studies have been made on the various combinations of these diagnostic 
modalities.
38
  
Many diagnostic tools are used in cases of suspected breast cancer 
as the famous triple assessment described in 1975
14
, which has 
dramatically reduced the use of open biopsy.
14,15 
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It was used principally for evaluating palpable breast lumps. Triple 
approach has achieved the highest level of diagnostic accuracy in which 
the results of clinical examination, imaging and fine needle aspiration 
cytology and/or tru-cut biopsy are combined.
16,17
 Hence a diagnostic 
accuracy exceeding 99% is achieved with the result of the three 
modalities.
18,76
 Interestingly diagnostic accuracy of comparable levels 
have been achieved with impalpable lesions in which, clinical 
examination is not much contributory.
19 
  The role of cytopathology in the diagnosis of breast disease is 
concerned with the examination of cells seen in the nipple discharges and 
those aspirated from solid and cystic lesions using a fine needle. The 
former is a well-established diagnostic test for carcinoma of the larger 
ducts, with or without Paget’s disease of the nipple, presenting with a 
blood stained discharge, but aspiration cytology is a newer technique, 
which is now finding its place in the breast surgeon’s diagnostic 
armamentarium.
9
 
In recent years the place of the rapid frozen section in the diagnosis 
of breast cancer has become diminished in importance and has been 
replaced by increasing emphasis on preoperative diagnosis using a 
combination of clinical examination, mammography and either biopsy, 
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using a wide bore cutting needle or aspiration cytology using a narrow 
hypodermic needle with rather than attempt to combine tissue diagnosis 
and mastectomy at one operation.
13
 
With realization that perhaps less radical surgery will give equal or 
improved survival as well as less postoperative morbidity, development 
of more reliable tests for metastatic disease there by making extensive 
surgery unnecessary, and finally the increasing tendency to involve the 
patient herself in the decision about the best method of treatment thus 
making accurate preoperative diagnosis very important.
6
 
Clinicians should distinguish between the two techniques, and it is 
recommended that the term biopsy be reserved for that which provides a 
histopathological diagnosis and “aspiration cytology” for that which 
provides cytopathological diagnosis. 
32
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CYTOPATHOLOGICAL DIAGNOSIS 
Fine needle aspiration cytology (FNAC) 
The History of FNAC 
Kun in 1847 had described a “new technique for the diagnosis of 
tumors”, which was the first report of using a needle method for 
harvesting tissue for microscopic examination. Random reports of this 
procedure were subsequently published.
6
  
FNAC was hardly recognized until the mid 1950s when awareness 
of this technique arose by Dr. Martin and Dr. Stewart (Head and Neck 
Surgeons, New York’s Memorial Hospital) and European pioneer 
workers from Stockholm Karolinska Radiumhemmet Hospital in Sweden. 
In contrast to Martin and Stewart who used thicker caliber (18 gauge) 
needles, the European workers popularized the technique of employing 
thin needles (22 gauge and higher) with an external diameter of 0.6mm or 
less for aspiration at different sites ranging through lymph nodes, prostate 
and breast.  
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Soderstrom and Franzen in Sweden and Lopes Cardozo in Holland 
became major proponents of FNAC studying thousands of cases each 
year5. 
These developments have contributed to a great extent resulting in 
the procedure today know as “fine needle aspiration cytology” (FNAC).  
The perfect volume, histopathological correlation, follow-up details 
with informative publications allowed for an ethos within the medical 
field for free reign of the procedure. Hence such a practice led to a new 
specialty called ‘clinical cytologist’ who examines the patient, and 
aspirates from the lesion, and subsequently prepares, reads the slide. The 
cytologist then arranges for onward referral. Therefore they served as a 
model for FNAC services for the whole world so that FNAC can be an 
active part of all sophisticated pathology departments.
29,30
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IN THE PRESENT ERA 
Fine needle aspiration cytology (FNAC) of the palpable breast 
masses has recently become a well accepted diagnostic technique, and 
has mostly replaced excision breast biopsy due to the following 
advantages.  It provides a sensitive, expedient and economical method of 
obtaining cytological material for examination. It can be done during an 
office visit without the need of anesthesia thus eliminating the cost of 
outpatient surgery. It also allows discussion with the patient of various 
treatment plans for the malignant mass on the same visit. It is most 
commonly used in combination with physical examination and 
mammography in the so-called “triple test” diagnostic triad, which is a 
highly accurate method of evaluating the breast masses. The recent 
renewed interest in this technique is also due to the fact that this 
procedure is safe, nontraumatic and repeatable.  
FNAC is carried out by cytotechnician and reported by the 
cytologist and no skill or expertise is needed and has no big learning 
curve to do the procedure. It can be repeated when necessary with ease.  
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Table 1: National Health Service Breast Screening Programme- 
Cytological Grading: 
 
Grade Result 
0 No epithelial cells present 
1 Scanty benign cells 
2 Benign cells 
3 Atypical cells present 
4 Highly Suspicious of malignancy 
5 Definitely Malignant 
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Table 2: Robinson Grading System 
CRITERIA 
SCORE 
1 2 3 
A) Cell 
dissociation 
Mostly in 
clusters 
Mixture of single 
cells & cells in 
clusters 
Mostly single 
cells 
B ) Cell size 1 – 2 x RBC size 3 – 4 x RBC size ≥ 5 x RBC size 
C) Cell uniformity Monomorphic 
Mildely 
pleomorphic 
Pleomorphic 
D ) Nucleoli Indistinct Noticeable 
Prominent or 
pleomorphic 
E ) Nuclear 
margin 
Smooth Folds Buds/Clefts 
F ) Chromatin Vesicular Granular 
Clumped & 
cleared 
 
Grade I: Score: 06–11  
Grade II: Score: 12–14  
Grade III: Score: 15 – 18  
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Cytology in different conditions
36
 
Benign mammary dysplasia 
When this lesion is aspirated one expects to see a few tight groups 
of duct cells, some adipose tissue and few stripped nuclei. Apocrine cells 
and foam cells are often seen, particularly when cysts are present. 
Fibroadenoma 
This lesion produces very cellular specimen. Duct cells are seen in large 
groups and sheets in honey coomb appearance surrounded by many 
stripped nuclei. Some nuclear pleomorphism of the duct cells usually 
present. The high cellularity and mild to moderate pleomorphism of 
fibroadenoma may lead to false diagnosis of malignancy. This is the 
tumour most likely lead to false positive diagnosis. 
Phyllodes tumour 
Variable cellularity, biphasic pattern similar to that of fibroadenoma. 
Cellular stomal component with spindle cells of various sizes and shapes. 
Variable cytological atypia and mitotic activity of stomal elements may 
be present. 
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Pregnancy and lactation 
Under hormonal stimulation the duct cells enlarge, round up, loose 
their adhesion and show prominent nucleoli. It helps in distinguishing 
these specimens from malignancy to note that the cells usually have little 
or no cytoplasm and that there is a protinaceous blue staining back 
ground in that numerous vacuoles appear, probably due to lipid droplets.   
Fat necrosis 
Aspirates show a ―messy mixture of degenerate fat cells, 
polymorphs, histiocytes and often a few giant cells. These are embedded 
in a blue staining background containing frequent holes, which are 
presumably dissolved lipid. 
Inflammatory conditions 
Acute inflammation (like mastitis and breast abscess) produces 
sheets of degenerate pus cells and other leucocytes usually with 
histiocytes scattered throughout. Duct cells, when present shows 
inflamatory changes like nuclear enlargement and cells degeneration. 
Granulomatous mastitis is characterized by a cellular aspirate 
demonstrating conspicuous numbers of lymphocytes, plasma cells and 
granulomas with epithelioid and multinucleated giant cells. Isolated 
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clusters of fibroblast and reactive ductal epithelial cells are also present. 
Occasionally necrosis may be seen. The cellular material from such 
aspirates should be carefully examined for the presence of acid-fast 
bacilli, fungi and parasites. Sarcoidosis shows no evidence of necrosis 
and cat scratch disease typically demonstrates micro abscess formation. 
Occasionally distinction between atypical mononuclear epithelioid 
histiocytes in granulomatous mastitis and neoplastic mammary epithelial 
cells may be difficult. 
Papilloma versus papillary carcinoma 
Histology and morphological distinction between the carcinoma and 
benign papillary lesions of the breast is difficult. It is recommended that 
definitive diagnosis be deferred to the histology unless there are 
unmistakable features of malignancy.  
Carcinoma of the breast 
A false diagnosis of breast carcinoma is unacceptable and it is to be 
avoided at all costs. It is much better to issue a false negative report and 
proceed to frozen section. 
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There are structured criteria for the diagnosis of malignancy by cytology, 
which are stratified into: 
1)  Structural alterations in the cells. 
2)  Changes in inter relationship of cells in cell clusters. 
3)  Indirect criteria. 
Structural modifications: 
Alterations of nuclear cytoplasmic ratio with disproportionate 
enlargement of nuclei. Hyperchromasia due to increased chromosomal 
content, aberrant chromatin pattern. Increased number of nucleoli beyond 
the normal. 
Multinucleation with nuclear atypia, abnormal mitotic figures. 
Marked thickening of nuclear membrane. 
Cytoplasmic changes enhanced by staining, such as pronounced 
basophilia/acidophilia. Presence of cytoplasmic inclusions like pigment 
granules, leukocytes and cellular debris. Atypical vacuolation especially 
in adenocarcinoma. 
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Well-differentiated carcinoma of the breast 
Diagnosis depends mainly upon the nuclear chromatin, which is 
finer and smoother than in benign duct cells, together with loss of 
adhesion of the cells. Other helpful factors are the greater cellularity of 
the specimens and the lack of stripped nuclei. These tumour cells are 
difficult to identify without experience. 
Moderately and poorly differentiated carcinoma of the breast 
These cases rarely present diagnostic difficulty. They show varying 
degrees of nuclear enlargement, loss of adhesions, pleomorphism 
abnormal nuclear chromatin and often- prominent nucleoli. Needle 
aspiration and/or scrapings from the Paget’s disease of the nipple show 
large single malignant cells with clear cytoplasm (Paget cells). Usually 
there is a dirty back ground with inflammatory cells. 
Other malignant tumours of the breast 
Colloid carcinoma  
It is suggested by the presence of sheets or columns and clusters of 
large tumour cells having compressed, crescent shaped nuclei with 
prominent nucleoli molded by one or two large cytoplasmic vacuoles 
(signet ring cells). 
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Epidermoid carcinoma (squamous) 
It is rare tumour that may originate from the metaplastic epithelium 
of the duct lining or from the skin covering the nipple. The cytology will 
show orange keratinised malignant cells with abnormal nuclei similar to 
ones described for squamous carcinoma of other sites. 
Medullary carcinoma 
In medullary carcinoma (brain like) aspirations may produce an 
abundance of large, ovoid or polygonal cells with adequate, vesicular, 
slightly basophilic cytoplasm and round or oval large nuclei with 
prominent, single nucleoli. Large number of lymphocytes may also be 
present. Breast sarcoma 
Breast angiosarcoma (lymphangiosarcoma and hemangiosarcoma)  
It is very rare; usually develop following radiotherapy to the breast. 
It is very difficult to differentiate by fine needle aspiration cytology. The 
lesion is composed of numerous slit like, irregular dilated vascular 
channels dissecting between the collagen bundles lined by atypical 
endothelial cells. 
  
  
 
32 
 
PITFALLS IN FNAC 
There are various drawbacks in FNAC which may take place in a 
variety of cases. Some of the drawbacks are due to sampling technique, 
while others are due to the unusual microarchitecture features or due to 
the stromal or cellular elements related to the lesion. Diagnostic errors 
may result in over-treatment or delay in the diagnosis and management.
40
 
In 1933, Stewart stated “until the pathologist has familiarized 
himself with the various pitfalls, errors are certain to occur” and “it must 
not be inferred that the diagnosis is always simple and that no errors have 
been made”.
41
 Hence interpretation of FNAC should always be 
accompanied by clinical and radiological opinion as the triple approach. 
 National Health Service Breast Screening Programme (NHSBSP) 
Cytology Guidelines also state that “under no circumstances should a 
cytological opinion of malignancy in the absence of mammographic and / 
or clinical evidence of malignancy be taken as authority for therapeutic 
surgery”.
34
 
Certain extrinsic factors may lead to error in diagnosis and hence 
influence the report of FNAC. These factors include: misleading history 
or clinical evidence, samples that are not representative, samples 
  
 
33 
 
contaminated by non-target tissue, artifacts due to poor processing of 
samples and dependence on and procedure failure of ancillary tests.
39
  
Numerous neoplastic and non-neoplastic conditions at various sites 
can cause difference in the general cytodiagnostic criteria which in turn 
can contribute to false negative and false positive reports adding to the 
causes of diagnostic pitfall. The discrepancy could be due to 
microarchitechture pattern, stromal or cellular component of target 
tissues.  
Hence pitfalls form unavoidable part of fine needle aspiration 
cytology. However its incidence can be reduced by taking necessary 
efforts in the diagnosis and by appropriately correlating cytology report 
with clinical evidence and radiological finding. Twice checking by 2 
different pathologists and numerous sampling when indicated with 
experience acquired by repeated practice of the procedure can help to 
minimize the occurrence of pitfalls by FNAC diagnosis.
12
  
As fine-needle aspiration cytology has become an important 
component in the investigation of palpable breast masses; false-negative 
results have become a major issue, requiring reconsideration of the 
specimen adequacy. The false-negative cases are commonly due to poor 
sampling technique, poor tumor localization, and the presence of a well-
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differentiated histology of the tumor. Small tumor size and non-palpable 
breast lesions are also commonly associated with false-negative and 
aspirate inadequacy.
42
 
False positive 
Fortunately a false positive diagnosis is rare and when clinically 
not supportive, it is advisable to go for tru-cut biopsy before the definitive 
treatment.
12
 
Inadequate sampling 
Inadequate sampling is another pitfall in the diagnosis of breast 
tumor by FNAC. In those with report as inadequate sampling, repeat 
aspiration has shown to increase the diagnostic accuracy of FNAC in 
diagnosing a breast lump. 
12
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HISTOPATHOLOGICAL DIAGNOSIS 
Biopsy of the breast Lesion 
The term “biopsy” (bios-life + opsis-vision) implies an 
examination of the tissue removed surgically. It includes not only the 
taking of the tissue but also its microscopic examination. The word 
biopsy appears to have been coined by the French dermatologist Ernest 
Henri Besnier in 1879. Even earlier, however Virchow has emphasized 
the fundamentals of biopsy and it’s value in the diagnosis of malignant 
tumors. Since then the histological study of tissue and other materials 
removed for the diagnostic purposes has become a cornerstone of many 
phases of medical practice.
12
 
The truth is that the only kind of evidence upon which a surgeon 
can wholly rely today is pathologic. The surgeon must have proof of the 
nature of the disease because his therapy is so different for different 
lesions. Benign lesions, in general require only harmless limited local 
excision, where as carcinoma requires a formidable and mutilating radical 
operation. Biopsy and microscopic study of the lesion, is necessary to 
prove the diagnosis for all lesions of the breast. The only question is what 
form of the biopsy should take. A number of different methods of 
obtaining tissue biopsy are in use.
20
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Clinicians should distinguish between the two techniques, and it is 
recommended that the term biopsy be reserved for that which provides a 
histopathological diagnosis and “aspiration cytology” for that which 
provides cytopathological diagnosis.
32
 
Methods of biopsy 
• Tru-cut biopsy 
• Intraductal biopsy 
• Smears of nipple secretion 
• Incision biopsy 
• Excision biopsy 
• Biopsy of lesions of the nipple. 
Tru-cut biopsy 
Surgeons have devised a variety of trocars and trephines for 
bringing out small cores of tissue from breast lesions. With them it is 
possible to obtain, tissue specimen that can be fixed embedded, and cut in 
the usual way. In 1938, Silverman introduced the needle that bears his 
name and it has come to be widely used for biopsy. Ackermann, at 
Delafied hospital has advised a good trocar with which a small core of 
tissue can be obtained. Another needle that is commonly used is the tru-
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cut needle. All these techniques have the disadvantage that they provide 
only a comparatively small specimen of the lesion, in which the 
architecture is not well shown and question such as invasion remain 
doubtful. The microscopic evidence is just not good enough. Trocar and 
trephine biopsy face the objection that they miss the lesion if very small.
12 
Intraductal biopsy 
Leborgne in Montevideo has devised a set of small instruments, 
dilators and loops curettes, which he inserts through the nipple ducts to 
reach the lesions and to secure small fragments of them. These fragments 
are sectioned and stained in the usual way.
21
 
Smears of nipple secretion 
The microscopic examination of nipple discharge smears shows a 
variety of cells including those from the duct epithelium, inflammatory 
cells and red blood cells. The best technique for collecting the fluid is to 
gently squeeze the nipple, noting the position of the nipple of the 
discharging duct and to place the one end of the microscopic slide on the 
nipple and make a thin film by smearing the discharge along the slide. 
The number of cells obtained is usually small and they dry quickly to 
enable good quality staining by the Romanowasky technique. 
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When several clusters of large duct cells are seen in a nipple 
discharge smear the presence of a papilloma or papillary carcinoma 
should be considered. There is no doubt that the smear technique is not a 
reliable method of diagnosis. Smears often fail to reveal carcinoma when 
it is present in the breast and they may give false positive diagnosis of 
carcinoma when it is not present. Secondly every kind of manipulation of 
a breast suspected of containing disease should be avoided for the fear of 
producing metastasis from possible carcinoma.
22 
Incision biopsy 
Some surgeons prefer incision biopsy and frozen section as the 
method of choice in proving a nature of tumor of the breast. Frozen 
section provides adequate microscopic evidence except in one type of 
neoplasm of the breast that requires good paraffin section. That is 
papillary type of neoplasm. It is difficult to distinguish papillary 
carcinoma from papilloma microscopically by frozen section. Preliminary 
biopsy as a separate operative procedure and careful study of paraffin 
sections should precede any definitive operative procedure.
12
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Excision biopsy 
Excision biopsy is carried out in the operation theater under general 
anesthesia, in which the entire lump is removed in-toto, only when there 
is high suspicion to support a benign lesion or rules out malignant lesion. 
It serves both as a diagnostic tool and therapeutic intervention, in which 
the lump is removed with adequate margins of normal tissue, wherein a 
further surgical procedure is not needed when diagnosed as benign lesion. 
Incision biopsy, in which a portion of the lesion is excised, is often 
reserved for diagnosis of lesion suspicious of malignancy, and in 
conditions where tru-cut biopsy is inconclusive. Hence, excision biopsy is 
indicated in patients with clinically suspicious lesions and lesions in 
which imaging or tissue studies are equivocal.
23-26
 The need for excision 
biopsy as a diagnostic tool has decreased with the increased use of tru-cut 
biopsy.
27
 
Biopsy from lesions of the nipple 
Lesions of the nipple epithelium, thickening, reddening, erosion 
which are not accompanied by a palpable tumor in the breast may quite 
properly be biopsied in the outpatient department.
12 
 
  
 
40 
 
Histological grading is an important determinant of prognosis that 
allows risk stratification. Several histologic grading systems are in use, in 
which some consider duct and gland differentiation and others the nuclear 
characteristics. Some grading systems include both. Scarff Bloom 
Richardson grading combines details of cell morphology with a 
measurement of differentiation and assessment of proliferation.  
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Table 3: Scarff Bloom Richardson Grading System 
Feature Score 
Tubule formation 
Majority of tumor - >75% 1 
Moderate degree - 10-75% 2 
Little or none - <10% 3 
Nuclear pleomorphism 
Small,uniform cells 1 
Moderate increase in size/variation 2 
Marked variation 3 
Mitotic counts-per 10 HPF(40xfields) 
0-5 1 
0-6 2 
>11 3 
Grade 1 (Well differentiated): Score 3-5 
Grade 2 (Moderately differentiated): Score 3-5 
Grade 3 (Poorly differentiated): Score 3-5 
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Table 4: Comparison of merits of surgical biopsy and aspiration cytology 43 
1. Diagnosis Histopathological Cytopathological 
2. Diagnostic Facility Narrow Broad 
3. Anesthesia Yes No 
4. Duration >5min <5min 
5. Report Available 1-2 days 1-2 Hours 
6. False Positive None Very Rare 
7. False Negative Few Some 
8. Cost High Low 
9. Specimen Obtained In operating Theatre As Out Patient 
10. 
Trauma and 
Skin Incision 
Yes Little if any 
 
Complication of breast aspirations 
No serious complication or problems are associated with fine 
needle aspiration cytology. A small hematoma may develop as a rare 
occurrence at the puncture site. This is more likely to happen with breast 
cancers than with benign diseases. Another minor complication that can 
occur with fine needle aspiration cytology is the superficial skin infection 
at the site of pierce. Although theoretically possible no cases of local 
recurrence or seeding of tumor by piercing with needle has been 
documented.
12,38
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MATERIALS AND METHODS 
 
Type of study 
It was a prospective study. 
Source of Data. 
Female patients with palpable lump in breast attending Coimbatore 
Medical College Hospital, Coimbatore formed the subject of this study.  
Period of study 
Between September 2014 to September 2015. 
Sample size 
76 patients. 
Inclusion criteria 
1. Age between 18 and 70 years. 
2. Palpable breast lump of variable duration. 
 Exclusion criteria 
1. Patients with recurrent malignancy 
2. Patient with acute and tender breast lump like breast abscess 
3. Frank malignant mass with skin ulceration 
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Ethical clearance 
The study protocol was reviewed by The Institutional Ethical 
Committee of the institution and permitted by it. 
Data collection 
A patient presenting to the outpatient department with palpable 
breast lump is subjected to detailed clinical history with physical 
examination and the information is entered in proforma. After obtained 
an informed and valid consent from the patient, fine needle aspiration 
cytology or tru-cut biopsy from the breast lump is performed.  
The procedure for obtaining the specimen is explained to the 
patient. A 10ml syringe bearing a 23-gauge needle (external diameter of 
0.6mm) is used. The lump is firmly but gently fixed by the locating hand 
with slight stretching of the overlying skin. Using an alcohol impregnated 
swab, the site to be aspirated is cleaned. Then with syringe firmly fixed 
and plunger closed to remove air from barrel, the needle is made ready 
for inserting. Patient is informed prior to puncturing the skin. The needle 
is introduced into skin with no air in the syringe barrel. With the needle at 
the anterior edge of the lump, negative pressure is applied using the 
thumb or with help of a syringe holder. Multiple passes are made through 
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the lesion, at varying angle of entry into the lump, slowly rotating the 
syringe without withdrawing the needle from skin. This is continued till a 
small droplet of fluid is visualized at the hub of the needle. The negative 
pressure is released and then the needle is withdrawn from the skin. The 
needle is separated from the syringe, and reattached to the syringe filled 
with air. The specimen is then expressed on a glass slide.  
In case of excess bleed from the aspirated site, it is best to interrupt 
the procedure and apply pressure to avoid hematoma formation. The 
procedure may be repeated in the same sitting from another angle or after 
1 week. Breast lesions are often deeper than they appear. If there is doubt 
about whether the lesion has been sampled, then re-aspiration using a 
longer needle may be necessary. If there is no resistance to the needle 
from a lump that appears clinically not to be a lipoma, then it is likely the 
lesion has been missed by the needle. Re-aspiration is advised, especially 
if the spread slide shows oily droplets throughout. Similarly, heavily 
blood stained aspirates may not be representative of the lesion.  
The smear was fixed with 95% alcohol and later stained with 
hematoxylin and eosin stain. The slides were then observed under 
microscope and graded accordingly.
6 
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The patients were subsequently subjected to Tru-cut biopsy using a 
tru-cut biopsy “gun” of 14-gauge needle. After administering Local 
Anesthesia, small incision was made over the breast lump and cannula 
introduced. The inner trocar is thrust forward approximately 2 cm and at 
almost the same time the outer cutting cannla is thrust over the inner 
trocar filling the inside notch with the breast tissue specimen. The 
specimen is then placed in a container of 10% neutral formalin.  
The cytological and tru-cut histological diagnosis was reported to 
the patient and where a diagnosis of malignancy was made, modified 
radical mastectomy (MRM) was performed and specimen sent for 
confirming by histo-pathological report. In addition, where the cytology 
slide reported as “inadequate”, repeat aspiration was performed before 
excision biopsy.  
  
  
 
47 
 
CYTODIAGNOSTIC CRITERIA  
The reports of Fine Needle Aspiration Cytology from breast lump  
Reports of the fine needle aspiration cytology from palpable lump 
in breast falls in 4 categories. 
10
  
1. Unsatisfactory (inadequate) cytology 
Insufficient numbers or absence of epithelial cells. The standard 
criteria for a “diagnostic aspirate” are not yet well defined. Providing that 
the cells are well preserve and they are not obscured by blood and/or 
inflamatory cells. A breast aspirate is considered to be satisfactory when 
there are more than 3 to 6 epithelial cell groups per slide and cellularity is 
adequate when there are more than 4-6 well- visualized cell groups. The 
unsatisfactory or inadequate sampling is due to, 
a. Scant cellularity. 
b. Air drying or distortion artifact  
c. Obscuring blood/inflammation. 4. Others. 
d. No malignant cells seen 
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This may be expanded to include the type of cells present and 
therefore suggest the type of lesion. For example, the presence of 
apocrine metaplasia together with foam cells suggests cystic mastopathy. 
Benign cells aspirated from the breast are duct cells, apocrine cells, foam 
cell, stripped nuclei, fat cells, lymphocytes and red cells. 
3. Malignant cells present 
This report must be used only when there is no doubt that the 
lesion is malignant; as such a report should result in the patient receiving 
definitive treatment for the breast cancer. It is possible not only to 
diagnose malignancy but also to report whether the tumour is well, 
moderately or poorly differentiated and whether or not there is 
lymphocytes response. It is not possible to determine the presence or 
absence of invasion cytologically. 
4. Cells present that are suspicious but not diagnostic of malignancy. 
Data entry and Analysis 
 Data entry and data analysis were done using MS Excel 2007. 
Appropriate statistical tests were applied. 
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RESULTS 
 
Table 5: Distribution of Patients according to their Age 
Age Group                 
(in completed years) 
Total 
Frequency Percentage % 
18-30 23 32 
30-40 17 24 
40-50 18 21 
50-60 13 18 
>60 5 5 
Total 76 100 
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Table 6: Age wise distribution of patients having Benign and 
Malignant Breast Lump 
Age Group         
(in completed 
years) 
Benign Malignant 
Frequency Percentage % Frequency Percentage % 
18-30 23 53 0 0 
30-40 12 28 5 15 
40-50 8 19 10 30 
50-60 0 0 13 40 
>60 0 0 5 15 
Total 43 100 33 100 
  
Table 5 shows that out of 76 women studied, age incidence ranged 
from 18 years to 70 years and the most common age group having breast 
lump was 18-30 years. 
 
Table 6 shows that the age prevalence for benign breast lesions 
range from 18-40 year and for malignant lesions range from 50-70 year. 
The commonest age for benign lesion was 25-35 year and for malignant 
lesion was 55-65 year.  
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Fig. 1: Distribution of patients according to Age 
 
 
Fig. 2: Age wise distribution of patients having Benign and 
Malignant Breast Lump 
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Table 7: The result of Fine Needle Aspiration Cytology 
Diagnosis Benign Malignant Suspicious Total 
Frequency 44 29 3 76 
 
Table 8: The result of Tru-cut Biopsy 
Diagnosis Benign Malignant Suspicious Total 
Frequency 43 31 2 76 
 
Table 9: The result of Histopathology 
Diagnosis Benign Malignant Total 
Frequency 43 33 76 
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Observations and results of benign lumps- FNAC  
Out of the 76 patients reported as having benign lesions by FNAC, 
43 were confirmed to have benign lesion by histopathology. False 
negative case was zero and false positive case was 1.   
Observations and results of malignant lumps- FNAC 
Of the total 33 cases of malignant lesions, FNAC had reported 29 
malignant, 1 benign and 3 suspicious lesion. There were 3 false negative 
cases and 1 false positive case. Inadequate (unsatisfactory) sampling 
report were observed in three cases, which on repeat fine needle 
aspiration cytology revealed malignancy, later confirmed by 
histopathology. 
Accuracy rate for diagnosing malignant lesions by FNAC is 
94.73%. 
Unsatisfactory specimen rate 3.9% 
Observations and results of benign lumps- Tru-cut Biopsy 
Of the 76 cases of benign report by tru-cut, 43 were confirmed by 
histopathology. There were zero false negative cases and zero false 
positive cases.  
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Observations and results of malignant lumps- Tru-cut Biopsy 
Of the total 33 cases of malignant lesions, tru-cut reported 31 as 
malignant, 2 suspicious lesion and false negative 2 and false positive 
zero. Two cases were reported as unsatisfactory (inadequate) sampling, 
which on excision biopsy revealed malignancy.  
Accuracy rate for diagnosing malignant lesions by tru-cut biopsy is 
97.36%. 
Unsatisfactory specimen rate 2.6% 
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Table 10: Histopathological reports of the Benign Breast Lesions 
Diagnosis Frequency 
Fibroadenoma 34 
Fibrocystic Disease 5 
Antibioma 1 
Benign Phylloides 1 
Duct Ectasia 1 
Acute Mastitis 1 
Total 43 
 
 
Table 11: Histopathological results of Malignant Breast Lesions 
Diagnosis Frequency 
Infiltrating Ductal Carcinoma 32 
Infiltrating Ductal Carcinoma with neuroendocrine 
differentiation 1 
Total 33 
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Table 12: The predictive value of FNAC of Palpable Breast Lump 
 
Test Result     
(FNAC) 
Disease   
(Malignant) 
Not Diseased 
(Benign) 
Total 
Positive 29 1 30 
Negative 3 43 46 
Total 32 44 76 
 
Table 13: The predictive value of Tru-cut Biopsy of the  
palpable breast lump 
 
Test Result     
(FNAC) 
Disease   
(Malignant) 
Not Diseased 
(Benign) 
Total 
Positive 31 0 31 
Negative 2 43 45 
Total 33 43 76 
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1. Sensitivity =                                                      × 100 
 
 
 
Sensitivity of FNAC= 90.62% 
Sensitivity of Tru-cut Biopsy= 93.93%                                                                               
 
2.  Specificity =      × 100                                               
 
 
Specificity of FNAC= 97.72% 
Specificity of Tru-cut Biopsy= 100%                                                                                  
  
True Positive 
True Positive + False Positive 
True Negative 
True Negative + False Positive 
  
 
59 
 
 
3. Positive Predictive Value =                               × 100                             
                                                                                      
PPV of FNAC= 96.66% 
PPV of Tru-cut Biopsy= 100% 
 
 
4. Negative Predictive Value =      × 100                            
 
NPV of FNAC= 93.47% 
NPV of Tru-cut Biopsy= 95.55% 
 
  
True Positive 
True Positive + False Positive 
True Negative 
True Positive+ False Negative 
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Inadequate sampling (Unsatisfactory report) 
 Of the total 33 cases of malignant lesions inadequate sampling 
report by FNAC were noted in 3 patients, which on repeat fine needle 
aspiration cytology revealed malignancy, and later was confirmed by 
histopathology. Similarly, 2 cases were reported as inadequate sampling 
by tru –cut biopsy, which on excision biopsy revealed malignancy. 
 
 
5. Inadequate sampling rate                           × 100                                  
                                                                                      
Inadequate sampling rate of FNAC= 3.9% 
Inadequate sampling rate of Tru-cut Biopsy= 2.6% 
 
  
No. of unsatisfactory report 
Total No. of cases 
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Table 14: Distribution of cases- Robinson cytological grading system 
Grade No. of Cases Percentage % 
1 4 14 
2 15 52 
3 10 34 
Total 29 100% 
 
 
Table 15: Distribution of cases- Scarff Bloom Richardson histological 
grading method 
 
Grade No. of Cases Percentage % 
1 2 6 
2 18 55 
3 13 39 
Total 33 100% 
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DISCUSSION 
 
Breast lump is a common complaint presented by patients at the 
surgical outpatient department in all major hospitals, with an anxiety of 
possible malignancy being extremely common.
4,5
 Accurate diagnosis of 
carcinoma has been a diagnostic dilemma since long. A differential 
diagnosis of the benign, traumatic and malignant lesions is very essential 
in early stages of the disease. It is extremely important that unnecessary 
surgeries or invasive treatment for benign diseases are minimized, and 
malignant lesions are aggressively managed in early stages. Breast is a 
common and important site for Fine Needle Aspiration Cytology 
(FNAC).  
There has developed increasing need to prove the diagnosis  of 
carcinoma breast at the initial visit by the patient in the form of needle 
cytology or biopsy.
3,12
 Hence it enables better evaluation and prudent 
preoperative communication with patient than with frozen section or 
excision biopsy which validated the physical examination diagnosis.  
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Enormous and tremendous success has been attained with the 
expansion of fine needle aspiration and cytology as the primary 
diagnostic tool in cancer for the past 30 years. Its use in diagnosing the 
presence of carcinoma prior to the surgical procedure and to direct the 
appropriate treatment has been well recognized. Moreover many studies 
have established the value of methodical use of tru-cut biopsy for the 
detection of carcinoma breast despite of the presence of good quality 
clinical, radiological, and cytological examinations.
11
  
Our current research was performed on 76 female patients having 
palpable lump in breast. After obtaining informed consent the patient was 
subjected to fine-needle aspiration cytology followed by tru-cut biopsy 
from the lump with subsequent surgical procedure as lumpectomy or 
modified radical mastectomy determined by the result from FNAC and 
histopathology report. The outcomes from aspiration cytology and the 
results of tru-cut biopsy were correlated with the final histopathologic 
report to observe how accurate fine needle aspiration cytology was when 
compared to tru-cut biopsy in assessing the cytohistologic correlation.  
The age range of the 76 women selected in our study was from 18 
years to 70 years. While the incidence for benign breast diseases ranged 
from 18 to 40 yrs, the prevalence of malignant lesions was from 50-70 
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yrs. The most frequent age group afflicted with benign breast lesions 
ranged from 25 to 35 years and with malignant lesions ranged from 55 to 
60 years.  
The most common pathology encountered among the patients in 
our study was fibroadenoma among (31patients). Subsequently 
fibrocystic disease was observed in 5 patients, antibioma in 1 patient, 
benign phylloides in 1 patient, duct ectasia in 1 patient, acute mastitis in 1 
patient and malignancy in 33 patients. Fibroadenoma has been regarded 
as an important cause for false positive diagnosis. We had one case of 
false positive report in this study.
70
 
Our study showed 33 malignant lesions, with ductal infiltrating 
carcinoma as commonest malignant lesion reported in FNAC and tru-cut 
biopsy. One case was reported as having infiltrating ductal Carcinoma 
with neuroendocrine differentiation. Malignant lesions were responsible 
for 43% of breast lumps (33 out of total 76 cases). While the peak 
incidence is observed in post menopausal women, it may be seen as early 
as in the third decade. In cytology it appears as much cellular smear, 
often with necrotic background, monomorphic cell population with 
variable cell pattern including conspicuous loss of cellular cohesion, 
numerous isolated single cells and variable degree of anisonucleosis.
33
 In 
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HPE depending on the grade, the tumor may form glands and tubules and 
show stromal desmoplasia, and contain round to oval nuclei with mitoses.  
In a study by Tiwari et al
56 on 91 patients showed the most 
common lesion to be fibroadenoma (39.6%). Other benign conditions as 
fibrocystic disease, galactocele, breast abscess, duct ectasia were 
responsible for 5.5%-7.7% of cases. In addition invasive ductal cancer 
was responsible for 6.6% of the 91 cases. In a study by A. Khemka et al.
6
, 
the commonest pathology was found to be fibroadenoma among 29 
patients with fibrocystic disease noted in 4 patients followed by 
malignancy observed in 13 patients. Sumaira Zareef et al
54 and 
Ashwin
12 also found the fibroadenoma commonest lesion of breast in 
their study.  
As described above, the purpose of our study was to deduce the 
diagnostic correlation of fine needle aspiration cytology and tru - cut 
biopsy when compared to the histopathologic result from breast lump. 
Hence, enabling us to conclude how accurate and reliable FNAC is as 
compared to Tru-cut biopsy in determining the pathology, which further 
facilitates in planning a definite surgery without giving objectionable 
final histology report of the specimen. 
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Analysis of the cytological reports in various series confirms the 
high diagnostic accuracy of FNAC. One year prospective study of FNAC 
and tru-cut biopsy of clinically palpable lump in breast with 
histopathology report correlation was performed at our hospital. In which 
FNAC showed benign breast lesion in 44 patients with suspicious 
observed in 3 patients and malignancy lesion observed in 3 patients and 
false positive report observed in 1 patient. The accuracy of fine needle 
aspiration cytology for diagnosing benign lesions was 100%. The overall 
sensitivity of FNAC in diagnosing a malignant lesion in this study was 
90.62%, and specificity was 97.72%,  
Analysis of tru-cut biopsy reports revealed higher diagnostic 
accuracy. Tru-cut biopsy showed benign breast lesions in 43 patients, 
suspicious in 2 patients and malignant in 31 patients with false negative 
report observed in 2 patients and false positive result of 0. Accuracy of 
tru-cut biopsy for benign lesions was 100%. The overall sensitivity of tru-
cut in diagnosing a malignant breast lesion in our study was 93.93%, 
specificity was 100%. 
The sensitivity of the concerned investigation is its statistical 
index. If the particular test result is positive, it certainly indicates that the 
disease is present. However, if the result is negative, then it doesn’t rule 
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out possibility of disease. In addition the effectiveness of the 
investigation to identify the patients not having the disease determines its 
specificity.  
The positive predictive value of a test is the likelihood of the 
patient with a positive result to have the disease and thus determining the 
diagnostic power of the test. Meanwhile the negative predictive value of 
the test determines the possibility of the patient with a negative result not 
to have the disease.  
The positive predictive value of a test indicates the probability of a 
patient with a positive result to have the disease. Hence, it shows the 
diagnostic power of the test while the negative predictive value of a test, 
on the other hand, indicates the probability of a patient with negative 
result not to have the disease. 
The positive predictive value of FNAC to diagnose a malignant 
breast lesion was 96.66% and negative predictive value was 93.47% in 
this study.  
The positive predictive value of tru-cut biopsy in diagnosing a 
malignant breast lesion in our study was 96.66% and negative predictive 
value was 93.47%. 
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Table 16: Comparison of various studies- Fine needle Aspiration 
cytology of Palpable breast lump 
 
Name of study Sensitivity Specificity 
Hussain M T
47
 90.9%, 100.00% 
Aziz M et al
48
 85.29% 100.00% 
Abdulrahman et al
51
 91.70% 100.00% 
O.N. Alema et al
57
 83.3%, 100.00% 
Sudarat et al
58
 92.50% 90.20% 
Ahmed HG
61
 92.60% 95.20% 
A.Khemka et al
6
 96.00% 100.00% 
Tiwari et al
56
 83.00% 100.00% 
Nggada HA et al
59
 95.70% 98.70% 
Muzaffar et al
72
 85.29% 100.00% 
Rubin J et al
46
 87.00% 100.00% 
Yeoh et al
64
 79.00% 98.00% 
Choi et al
74
 77.70% 99.20% 
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Table 17: Comparison of various studies- Fine needle Aspiration 
cytology of Palpable breast lump
73 
Name of study Sensitivity Specificity 
Husain and Rikabi et al 98.10% 100.00% 
Lacambra et al 96% 99% 
Ahmed et al 94.64% 91.30% 
Bdour et al 97% 100% 
Brunner et al 95% 100% 
Kulkarni et al 97.70% 94.20% 
Homesh et al 92.30% 94.80% 
Gukas et al 88.90% 96.80% 
Our Study 93.93.% 100% 
 
As described above, the positive and negative predictive values of 
a test are the statistical indices which measure the performance of a test 
by measuring its “predictive value” which reflects the diagnostic power 
of the test. It depends on the sensitivity, specificity and disease 
prevalence. In this regard, Franco et al.
75
, in his study of 300 patients on 
the utility of FNAC, reported a positive predictive value of 100% and a 
negative predictive value of 92%. A very large study of 1,297 patients 
was done by Choi et al.
74
 on correlation of FNAC with histopathology 
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reports, and found the positive predictive value to be 98.4% and a 
negative predictive value of 88%.  
Our study had 3 false negative reports. Even though these reports 
can be considered as sampling error, its effect on treatment could be 
noticeable. A failed aspiration reported in respect of a breast lump is best 
regarded as a non-report and repeat biopsy is sensible. Cellular 
fibroadenoma and papilloma bear a risk in this regard. Numerous other 
studies have shown a false positive report of 0-10%
36
. Care must be taken 
to prevent false positive reporting, hence avoiding an incorrect 
conclusion.  
The lesions having possibility of false positive report are papillary 
lesions, atypical epithelial hyperplasia, atypia of ductal epithelium in a 
cyst. And the likelihood of a false negative report is present in low grade 
malignancy, complex proliferative lesion and in tumors with central 
necrosis, small cell carcinoma. In the context of breast pathologies, the 
main advantage of FNAC is that there are very few false positives in 
distinguishing benign and malignant lesions. Silverman et al. also showed 
in his works that fine needle aspiration cytology in contrast to tru-cut 
biopsy has higher positive predictive value in detecting carcinoma and 
locally recurrent disease.
69
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The presences of unsatisfactory and inadequate sampling due to 
less or no cellular material in the report, lead us to speculate for any error 
in the method of aspiration. In this study there were three aspirations 
reporting unsatisfactory, thus resulting in an inadequate sampling rate of 
3.9%. The percentage of inadequate sampling rate reported in various 
studies varied from 9% to 18%.
17
 
FNAC is the reliable, fast, cost effective and simple procedure for 
breast lump diagnosis. It is a valuable method although moderately less 
sensitive than tru-cut biopsy. FNAC is highly predictive and accurate for 
breast lesions when used in context of other diagnostic modalities 
(clinical & radiological = triple test).
13
 On the other hand, Yong et al. 
preferred the FNAC over tru-cut biopsy as it produced less complication, 
able to perform multidirectional sampling and there was a technical 
problem of immobilizing the lump while using tru-cut needle. 7,8 Few 
advantages noted with tru – cut biopsy was that it provided preoperatively 
the histologic type of tissue and valuable information on prognostic 
parameters such as expression of oncogenes and anti-oncogenes (c-erbB2 
& p53), receptor status, proliferative activity and ploidy. This will enable 
the oncologist and surgeon to choose the ideal therapeutic measure with 
appropriate neo - adjuvant chemotherapy. 
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The tru-cut biopsy of palpable breast lesions based on histological 
study of tissue specimens has the advantage of providing preoperatively 
the histological type and information on prognostic parameters (receptor 
status, proliferative activity, ploidy, and expression of oncogenes and 
antioncogenes such as c-erbB-2 and p53) which will guide the surgeon 
and the oncologist for ideal modern therapeutic strategy in surgical 
decision making.
13
 It also permits the eventual use of neoadjuvant 
therapy. 
 Hatada et al. stated that combination of FNAC and tru-cut biopsy 
has higher sensitivity and accuracy in diagnosis of breast lumps. Ibrahim 
et al. reported that FNAC may sample larger or slightly different areas of 
breast tissue, while tru-cut biopsy represented only one area of the mass. 
So combination of the two procedures may decrease the false negative 
results. 
Different authors have followed different cytologic grading 
systems, some have even tried to compare them and evaluate the most 
suitable.
30
 
Frias et al studied 100 cases of invasive ductal carcinoma, 
cytologic grading was done using Robinson’s method and histological 
grading was done using SBR method. A statistically significant 
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association was observed between cytologic and histologic grades and 
between cytologic grade. Similarly, cell dissociation, cell uniformity and 
the appearance of nuclear margins all displayed a positive correlation 
with regional metastasis.
3
 
In a study done by Khan et al which included 43 cases of 
infiltrating carcinomas, cytologic grading was done by Robinson’s 
grading method and histologic grading was done by SBR grading 
method. Cytologic grading was found to be fairly comparable with 
histologic grading, difference between the two grading methods was 
insignificant in all the three of the six parameters studied, cell 
dissociation, nucleoli and chromatin pattern were the most influencing.
33
 
Chhabra et al studied 60 cases of breast carcinoma where 
Robinson’s method was used for grading cytologic smears and SBR 
grading was used for histologic grading. There was agreement between 
cytologic grade and histologic grade in 65% of the tumors. The histologic 
grade correlated positively with cytologic grade. The study also showed 
that extent of cell dissociation and nucleoli were the most influential 
features.
24
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CONCLUSION 
 
In our study the accuracy rate of Tru-cut biopsy has reported to be 
more than the accuracy rate of FNAC. Despite the ability of tru – cut 
biopsy to provide histologic diagnosis with additional details on the 
receptor status, tumor grade, and type with lymphovascular invasion, 
FNAC stands as an effective and valid tool as the first line diagnostic 
modality in the preoperative diagnosis of both benign and malignant 
lesions. 
Analysis of various cytological reports showed the high diagnostic 
accuracy of fine needle aspiration cytology. In fine needle aspiration 
cytology 44 patients had benign breast lesion, suspicious lesion in 3 and 
malignant lesion in 29 with a false negative result in 3 patients and false 
positive result in 1 patient. The diagnostic accuracy of FNAC for the 
benign lesions was 100%. The sensitivity of FNAC in detecting a 
malignant lesion in this study was 90.62% and with a specificity of 
97.72%, a positive predictive value of 96.66% and negative predictive 
value of 93.47%.  
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Analysis of Tru-cut biopsy revealed higher diagnostic accuracy. In 
Tru-cut biopsy 43 patients had benign breast lesion, suspicious in 2 and 
malignant in 31 patients with a false negative result in 2 patients and a 
false positive result in 0. The diagnostic accuracy of tru-cut biopsy in 
benign lesion was also 100%. The overall sensitivity of tru-cut in 
diagnosing a malignant breast lesion in this study was 93.93%, specificity 
was 100%, positive predictive value of 100% and negative predictive 
value of 95.55%.  
The sensitivity, specificity, and diagnostic efficacy observed in our 
data by FNAC were comparable to those observed in Tru-cut biopsy and 
those given in other texts. The FNAC procedure is easy, reliable, 
repeatable, and patient friendly. It is also a simple diagnostic test which 
can be implemented in busy clinic settings and does not call for too much 
preparation or expensive equipment. A high positive predictive value and 
a high sensitivity indicate that a positive report of fine needle aspiration 
cytology confirms the final diagnosis of the disease when correlated to 
the histologic report. A high negative predictive value and a high 
specificity reveal the high accuracy rate of FNAC in diagnosing a 
malignant lesion of the breast.  
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In addition, Robinson cytological grading system correlates 
precisely with the histological grade. A positive correlation was observed 
between Robinson cytological grading system and Scarff Bloom 
Richardson histological grading system. Discordance between cytologic 
grading and histologic grading was seen in few cases which may be due 
to sampling error, the presence of different degrees of atypia within the 
same tumor and subjective nature of grading process. Cytologic grading 
allows prognostic evaluation of breast carcinoma along with diagnosis 
without additional morbidity or expense to the patient. Hence it is 
recommended that cytological nuclear grade should appear in FNAC 
reports of ductal breast carcinoma for proper management.  
Thus, FNAC is a very important diagnostic tool in palpable breast 
lumps; its results show a high degree of correlation with the final 
histopathology report. To conclude, the results obtained by FNAC for a 
lump in breast especially in suspicion of malignancy clinically, is equal 
and in par with tru-cut in various aspects and outstands tru-cut biopsy in 
diagnosing benign diseases, and hence the simple OP procedure of FNAC 
done with ease by cytotechnician and diagnosed by pathologist is a 
widely acceptable procedure for diagnosing breast lumps.   
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ANNEXURE I 
 PHOTOGRAPHS 
       
    
 
     
   
  
 
 
 
Cytology Result of Malignant Lesion 
Histological appearance of 
Invasive ductal Carcinoma 
Histological appearance of 
Fibroadenoma 
Cytology Result of Benign Lesion 
  
ANNEXURE II 
 
 
 
 
 
 
 
 
 
 
 
 
  
FNAC from Breast Lump 
Tru-cut Biopsy Needle 
  
PROFORMA FOR COLLECTING THE DATA 
 
Case No. 
NAME:         
 D.O.A  
AGE:         
 D.O.O:  
SEX:          
 D.O.D 
OCCUPATION:  
ADDRESS: 
CHIEF COMPLAINTS:  
1) Lump 
2) Pain 
3) Discharge from nipple  
4) Retraction of nipple  
5) Other complaints 
 
HISTORY OF PRESENTING ILLNESS:  
1) PAIN: 
a. Duration 
b. Time and mode of onset 
c. Site of pain: 
d. character of pain  
  
e. radiation of pain 
f. Aggravating factors and Reliving factors 
 
PAST HISTORY 
1) History of similar complains 
2) Duration 
3) Treatment taken 
4) History of previous surgeries 
5) History suggestive of Hypertension/ Diabetes/ Tuberculosis 
 
PERSONAL HISTORY 
Diet: Vegetarian/ Mixed 
Habits: Smoking/ Alcohol/ Tobacco  
Bowel habits and habits Bladder\ 
Sleep 
 
FAMILY HISTORY 
Marital status 
Similar illness in other family members 
 
  
  
MENSTRUAL HISTORY  
Age of menarche  
Dysmenorrhea  
L. M. P. 
Vaginal discharge 
 
GENERAL PHYSICAL EXAMINATION  
1. General survey 
2. Body build and nourishment 
3. Appearance 
4. Attitude: Restless/ Quiet 
5. Dehydration: Mild/ Moderate/ Severe/ Nil 
6. Anaemia/ Jaundice/ Clubbing/ Cyanosis/ Lymphadenopathy/ Pedal 
oedema  
7. Pulse 
8. Temperature 
9. Respiratory rate 
10. Blood pressure 
 
LOCAL EXAMINATION  
1. INSPECTION BREAST 
Position 
Size and shape 
Any puckering or dimpling Skin over the breast NIPPLE 
  
Position  
Size and shape 
Surface 
Discharge 
AREOLA 
ARM AND THORAX 
AXILLA AND SUPRACLAVICULAR FOSSA 2. PALPATION 
Local rise of temperature Tenderness 
Situation 
Size and shape 
Surface and margin 
Consistency 
Fluctuation 
Fixity to the skin 
Fixity to the breast tissue 
Fixity to the underlying fascia and muscles Fixity to the chest wall 
Palpation of the nipple EXAMINATION OF LYMPH NODES Pectoral 
group 
Brachial group 
Subscapular group 
Central group 
Apical group 
cervical 
  
 RECTAL EXAMINATION 
VAGINAL EXAMINATION 
SYSTEMIC EXAMINATION 
•  Cardiovascular system 
• Respiratory system 
• Central nervous system 
• Genito-urinary system 
• Abdominal examination 
 
INVESTIGATIONS  
1. Blood: Hb % 
2. TLC 
3. DLC 
4. BT 
5. CT 
6. ESR 
7. Blood group and Rh type 
8. Urine: Albumin/ Sugar/ Microscopy  
9. Chest x-ray 
10. HIV & HbsAg  
12. Others 
DIAGNOSIS MANAGEMENT  
  
SURGICAL 
Pre-operative instructions Type of Anaesthesia Type of incision 
Post-operative instructions Post-operative period 
Post-operative complication management 
  
  
 CONSENT FORM 
It has been explained to me in my mother tongue and I completely 
understand my condition, its related complications and the treatment 
options available. I have been explained in detail regarding this study 
COMPARATIVE STUDY BETWEEN FINE NEEDLE 
ASPIRATION CYTOLOGY AND TRU-CUT BIOPSY IN THE 
DIAGNOSTIC ACCURACY OF BREAST CANCER IN 
COIMBATORE MEDICAL COLLEGE HOSPITAL. I hereby give 
my consent to participate in the above mentioned study. 
 
 
…………………………     ……………………… 
Signature / left thumb impression of parent  Date: 
  
  
xg;g[jy; gotk;; [ ; ;; [ ; ;; [ ; ; 
 
bgah;     : 
taJ     : 
ghypdk;    : 
Kfthp    : 
 
muR nfhit kUj;Jtf; fy;Yhhpapy; bghJ kUj;Jt mWit 
rpfpr;ir Jiwapy; gl;l nkw;gog;g[ gapYk; khztp kU. ehd;rp uh$h ;;;
mth;fs; nkw;bfhs;Sk; "Ez;Crp capuqtpay; kw;Wk; l;+fl; ; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;
Jy;ypak; ; ;; ;; ; - xU xg;gPl;L Ma;t[; ; ; [; ; ; [; ; ; [" gw;wpa Ma;tpy; bra;Kiw kw;Wk; 
midj;J tpsf;f';fisa[k; nfl;Lf; bfhz;L vdJ re;njf';fis 
bjhpt[gLj;jpf; bfhz;nld; vd;gij bjhptpj;Jf; bfhs;fpnwd;. 
ehd; ,e;j Ma;tpy; KG rk;kjj;JlDk;/ Ra rpe;jida[lDk; 
fye;J bfhs;s rk;kjpf;fpnwd;. 
,e;j Ma;tpy; vd;idg; gw;wpa midj;J tpgu';fs; ghJfhf;fg; 
gLtJld; ,jd; Kot[fs; Ma;tpjHpy; btspaplg;gLtjpy; Ml;nrgiz 
,y;iy vd;gij bjhptpj;Jf; bfhs;fpnwd;. ve;j neuj;jpYk; ,e;j 
Ma;tpy; ,Ue;J ehd; tpyfpf; bfhs;s vdf;F chpik cz;L 
vd;gija[k; mwpntd;. 
 
,lk; 
njjp   
  
MASTER CHART 
No Name Age (years) FNAC Report Tru-cut Report Surgery Performed Histopathology Report 
1 Bhuvaneshwari  20 Benign Benign Excision Fibroadenoma 
2 Manju 18 Benign Benign Excision Fibroadenoma 
3 Pavithra 20 Benign Benign Excision Benign Phylloides Tumor 
4 Thilagavathy 57 Malignant Malignant MRM Invasive Ductal CA 
5 Rajalakshmi 32 Benign Benign Excision Fibroadenoma 
6 Lakshmi 60 Malignant Malignant MRM Invasive Ductal CA 
7 Ruckmani 60 Malignant Malignant MRM Invasive Ductal CA 
8 Kaliyammal 70 Malignant Malignant MRM Invasive Ductal CA 
9 Umarani 50 Malignant Malignant MRM Invasive Ductal CA 
10 Sheela 27 Benign Benign Excision Fibroadenoma 
11 Prabhavathy 27 Benign Benign Excision Fibroadenoma 
12 Jaibunisha 60 Malignant Malignant MRM Invasive Ductal CA 
13 Sakila 45 Malignant Malignant MRM Invasive Ductal CA 
14 Palaniyammal 55 Malignant Malignant MRM Invasive Ductal CA 
15 Rahana 18 Benign Benign Excision Fibroadenoma 
16 Santhi 50 Malignant Malignant MRM Invasive Ductal CA 
17 Kulandiyammal 50 Malignant Malignant MRM Invasive Ductal CA 
18 Devi* 50 Benign Fibrous tissue MRM Invasive Ductal CA 
  
19 Hayarnisha 43 Malignant Malignant MRM Invasive Ductal CA 
20 Savithri 59 Blood components Malignant MRM Invasive Ductal CA 
21 Amiritham 50 Benign-Nipple adenoma Fibrofatty tissue Excision Fibroadenoma 
22 Priya 24 Benign Fibrofatty tissue Excision Antibioma 
23 Revathi 23 Benign Benign Excision Fibroadenosis 
24 Rajeshwari 58 Malignancy Malignant MRM Invasive Ductal CA 
25 Shanthi 37 Benign Benign Excision Fibroadenoma 
26 Maharaj Banu 42 Malignant Malignant MRM Invasive Ductal CA 
27 Rathana 36 Malignant Malignant MRM Invasive Ductal CA 
28 Ajmunisha 40 Benign Benign Excision Fibroadenoma 
29 Sandhiya 30 Benign Benign Excision Fibroepithelial Polyp 
30 Saroja 33 Benign Benign Excision Fibroadenoma 
31 Jagajothi 43 Benign Benign Excision Fibrocystic disease 
32 Palanathal 45 Benign Benign Excision Fibrocystic disease 
33 Farina 18 Benign Benign Excision Tubular Adenoma 
34 Mohanambal 64 Malignant Malignant MRM Invasive Ductal CA 
35 Elizabethrani 47 Benign Benign Excision Fibroadenoma 
36 Ayyammal 35 Benign Benign Excision Fibroadenoma 
37 Sokammal 26 Benign Benign Excision Fibroadenoma 
38 Sumaiya 34 Benign Benign Excision Fibroadenoma 
39 Sundhari 46 Benign Benign Excision Ductectasia 
  
40 Niraikalai 30 Benign Benign Excision Fibroadenoma 
41 Backiyam 23 Benign Benign Excision Acute Mastitis 
42 Preetha 37 Benign Benign Excision Fibroadenoma 
43 Ponnammal  45 Malignant Malignant MRM Invasive Ductal CA 
44 Ambika 24 Benign Benign Excision Fibroadenoma 
45 Nagarathinam 28 Benign Benign Excision Fibroadenoma-complex 
46 Jothi  55 Malignant Malignant MRM Invasive Ductal CA 
47 Umadevi 62 Malignant Malignant MRM Invasive Ductal CA 
48 Savithri 51 Malignant Malignant MRM Invasive Ductal CA 
49 Devanai 50 Benign Benign Excision Fibrocystic Disease 
50 Karuppammal 40 Malignant Malignant MRM Invasive Ductal CA 
51 Chandra 55 Malignant Malignant MRM Invasive Ductal CA 
52 Vijayalakshmi 45 Benign Benign Excision Fibrocystic Disease 
53 Santhi 29 Benign Benign Excision Fibrocystic Disease 
54 Pavithra 23 Benign Benign Excision Fibroadenoma 
55 Vijaya  40 Benign Benign Excision Fibroadenoma 
56 Sharmila 28 Benign Benign Excision Fibroadenoma 
57 Sampoornam 62 Malignant Malignant Excision Invasive Ductal CA 
58 Mariyam 40 Benign Benign Excision Fibroadenoma 
59 Poorani 57 Malignant Malignant MRM Invasive Ductal CA 
60 Papayee 70 Malignant Malignant MRM Invasive Ductal CA 
  
61 Pavithra 21 Benign Benign Excision Fibroadenoma 
62 Fathima 45 Malignant Malignant MRM Invasive Ductal CA 
63 Angaleshwari 34 Benign Benign Excision Fibroadenoma 
64 Rajammal 40 Malignant Malignant MRM Invasive Ductal CA 
65 Vijaya 32 Benign Benign Excision Fibroadenoma 
66 Malathi 57 Malignant Malignant MRM Invasive Ductal CA 
67 Allmelu 43 Malignant Malignant MRM Invasive Ductal CA 
68 Suvitha * 36 Benign Benign Excision Invasive Ductal CA 
69 Vanitha Banu 40 Malignant Malignant MRM Invasive Ductal CA 
70 Sundari  32 Benign Benign Excision Fibroadenoma 
71 Bhuvaneshwari 46 Benign Benign Excision Fibroadenoma 
72 Amsaveni 20 Benign Benign Excision Fibroadenoma 
73 Thangammal 55 Malignant Malignant MRM Invasive Ductal CA 
74 Geethalakshmi 30 Benign Benign Excision Fibroadenoma 
75 Gomathy 29 Benign Benign Excision Fibroadenoma 
76 Bommi 30 Benign Benign Excision Fibroadenoma 
 
 
